E. coli epidemic baffles doctors

A highly virulent strain of E. coli that has already killed two people and infected around 800 (most of whom live or had visited northern Germany) has proved an enigma for epidemiologists.

Written byCristina Luiggi
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

MAXEXPHOTO / DREAMSTIME.COM

A highly virulent strain of E. coli that has already killed two people and infected around 800 (most of whom live or had visited northern Germany) has proved an enigma for epidemiologists. In particular, they are at a loss to explain the unusually high number of cases of haemolytic uraemic syndrome (HUS), a severe kidney illness, that the bacteria has caused. The epidemic has been linked to the consumption of raw cucumbers, tomatoes, and lettuce and has affected mostly women, ScienceInsider reports. According to Nature, a clinical trial for an experimental antibody called eculizumab (brand names Soliris or Alexion) is currently underway as a treatment for the infection.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Accelerating Recombinase Reprogramming with Machine Learning

Accelerating Recombinase Reprogramming with Machine Learning

Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo

Products

waters-logo

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

zymo-research-logo

Zymo Research Partners with Harvard University to Bring the BioFestival to Cambridge, Empowering World-class Research

10x-genomics-logo

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA